Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SuBDuE: Zoledronic Acid for Bone Turnover Suppression in Breast Cancer
NCT01344967Phase 3Completed
- Sponsor
- University Health Network
- Start
- Feb 2009
- Primary completion
- Aug 2011
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in bone metastases, sponsored by University Health Network. Started Feb 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT01344967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344967.